Miniature model of the human nose reveals early events of SARS-CoV-2 and RSV infection
Researchers anticipate that the human nose organoid system would help accelerate the transfer of lab-developed therapeutics to the bedside.
Read moreResearchers anticipate that the human nose organoid system would help accelerate the transfer of lab-developed therapeutics to the bedside.
Read moreBaylor College of Medicine researchers are contributing to the development of antiviral drugs to treat people with COVID-19.
Read moreImmunofluorescence staining of human nose organoid cultures infected with SARS-CoV-2, the virus that causes COVID-19.
Read moreNovel vaccine candidate will be easy to produce at large scale and cost-effective, especially in low- to middle-income countries.
Read more